- ISIN
- US26923G3011
- CUSIP
- 26923G301
- Inception Date
- Dec 16, 2014
- Region
- North America (U.S.)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- LifeSci Biotechnology Clinical Trials Index
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Multi-Cap
- Asset Class Style
- Blend
- Assets Under Management
- $41M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BBC Performance Chart
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is up 23.8% since the beginning of the year. BBC is currently trading at $48 per share. Investors who bought $1,000 worth of BBC shares 5 years ago would now be looking at an investment worth $993.
Loading charts...
Returns By Period
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has returned 23.79% so far this year and 151.23% over the past 12 months. Over the last ten years, BBC has returned 10.98% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Virtus LifeSci Biotech Clinical Trials ETF
- 1D
- 4.97%
- 1M
- 11.76%
- YTD
- 23.79%
- 6M
- 18.79%
- 1Y
- 151.23%
- 3Y*
- 26.34%
- 5Y*
- -0.15%
- 10Y*
- 10.98%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
BBC Monthly Returns History
Based on dividend-adjusted daily data since Dec 17, 2014, BBC's average daily return is +0.05%, while the average monthly return is +1.03%. At this rate, an investment would double in approximately 5.6 years.
Historically, 53% of months were positive and 47% were negative. The best month was Dec 2023 with a return of +25.1%, while the worst month was Jan 2016 at -33.9%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 9 months.
On a daily basis, BBC closed higher 52% of trading days. The best single day was Nov 9, 2016 with a return of +10.7%, while the worst single day was Mar 16, 2020 at -12.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.92% | 3.98% | -1.98% | 5.48% | 1.51% | 7.10% | 23.79% | ||||||
| 2025 | -3.85% | -11.63% | -13.78% | 8.84% | -4.71% | 6.21% | 12.11% | 4.80% | 20.24% | 18.19% | 17.27% | 3.65% | 63.77% |
| 2024 | 3.81% | 18.46% | -3.12% | -10.43% | 1.62% | -4.73% | 14.23% | -2.88% | -0.29% | 1.75% | -3.40% | -11.95% | -1.11% |
| 2023 | 10.58% | -9.56% | -12.29% | 5.00% | 5.69% | -1.50% | 0.52% | -10.85% | -8.61% | -8.99% | 9.85% | 25.08% | -1.80% |
| 2022 | -22.31% | -4.80% | -1.94% | -21.07% | -12.26% | 11.61% | 11.18% | 5.54% | -3.01% | 5.28% | -1.60% | -1.85% | -35.13% |
| 2021 | 6.07% | 3.39% | -5.53% | -1.30% | -5.29% | 4.00% | -11.59% | 8.13% | -4.27% | -2.93% | -8.49% | -5.10% | -22.31% |
Benchmark Metrics
Virtus LifeSci Biotech Clinical Trials ETF has an annualized alpha of -2.49%, beta of 1.21, and R2 of 0.31 versus S&P 500 Index. Calculated based on daily prices since December 17, 2014.
- This ETF participated in 142.68% of S&P 500 Index downside but only 117.67% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.31 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -2.49%
- Beta
- 1.21
- R²
- 0.31
- Upside Capture
- 117.67%
- Downside Capture
- 142.68%
Expense Ratio
BBC has an expense ratio of 0.79%, placing it in the medium range.
Return for Risk
Risk / Return Rank
BBC ranks 94 for risk / return — in the top 94% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.17 | ||
| Sortino ratioReturn per unit of downside risk | +1.84 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.37 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 10.08 | 2.78 | +7.29 |
| Martin ratioReturn relative to average drawdown | 29.53 | 12.44 | +17.09 |
Dividends
Dividend History
Virtus LifeSci Biotech Clinical Trials ETF provided a 1.37% dividend yield over the last twelve months, with an annual payout of $0.66 per share. The fund has been increasing its distributions for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.66 | $0.66 | $0.24 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.00 | $0.15 |
Dividend yield | 1.37% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
Monthly Dividends
The table displays the monthly dividend distributions for Virtus LifeSci Biotech Clinical Trials ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.66 | $0.66 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.24 | $0.24 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.08 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Virtus LifeSci Biotech Clinical Trials ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Virtus LifeSci Biotech Clinical Trials ETF was 76.85%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Virtus LifeSci Biotech Clinical Trials ETF drawdown is 20.54%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -76.85%Apr 2025 | 4y 1mo | — | 5y 4moFeb 2021 - now |
2016 bear market2016 | -58.50%Nov 2016 | 1y 3mo | 3y 1mo | 4y 5moJul 2015 - Dec 2019 |
COVID crash2020 | -40.47%Mar 2020 | 2mo 23d | 1mo 24d | 4mo 17dDec 2019 - May 2020 |
2020 correction2020 | -16.61%Sep 2020 | 2mo 16d | 2mo 20d | 5mo 6dJun 2020 - Nov 2020 |
2015 correction2015 | -15.83%Apr 2015 | 1mo 11d | 29d | 2mo 10dMar 2015 - May 2015 |
Drawdown Indicators
| BBC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -56.78% | -20.07% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -9.10% | -6.00% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -18.90% | -35.55% |
Max Drawdown (5Y)Largest decline over 5 years | -71.97% | -25.43% | -46.54% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -33.92% | -42.93% |
Current DrawdownCurrent decline from peak | -20.54% | -1.80% | -18.74% |
Average DrawdownAverage peak-to-trough decline | -37.09% | -10.71% | -26.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 2.03% | +3.11% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with BBC
Add Virtus LifeSci Biotech Clinical Trials ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BBC